Nanosonics Limited

OTCPK:NNCS.F Stock Report

Market Cap: US$566.7m

Nanosonics Valuation

Is NNCS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NNCS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NNCS.F ($2.1) is trading below our estimate of fair value ($3.51)

Significantly Below Fair Value: NNCS.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NNCS.F?

Key metric: As NNCS.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NNCS.F. This is calculated by dividing NNCS.F's market cap by their current earnings.
What is NNCS.F's PE Ratio?
PE Ratio69.7x
EarningsAU$12.97m
Market CapAU$913.68m

Price to Earnings Ratio vs Peers

How does NNCS.F's PE Ratio compare to its peers?

The above table shows the PE ratio for NNCS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.2x
AVNS Avanos Medical
31.5xn/aUS$687.1m
STAA STAAR Surgical
54.9x33.6%US$1.2b
OSUR OraSure Technologies
23.2x-46.8%US$269.3m
VIVO Meridian Bioscience
35.2xn/aUS$1.5b
NNCS.F Nanosonics
69.7x24.0%US$913.7m

Price-To-Earnings vs Peers: NNCS.F is expensive based on its Price-To-Earnings Ratio (69.7x) compared to the peer average (36.4x).

Price to Earnings Ratio vs Industry

How does NNCS.F's PE Ratio compare vs other companies in the US Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MHUA Meihua International Medical Technologies
1xn/aUS$9.00m
PAVM PAVmed
0.5x-90.0%US$6.89m
UTRS Minerva Surgical
n/an/aUS$8.00
No more companies available in this PE range
NNCS.F 69.7xIndustry Avg. 34.6xNo. of Companies8PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NNCS.F is expensive based on its Price-To-Earnings Ratio (69.7x) compared to the US Medical Equipment industry average (34.6x).

Price to Earnings Ratio vs Fair Ratio

What is NNCS.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NNCS.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio69.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NNCS.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NNCS.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$2.10
US$2.15
+2.3%
11.2%US$2.48US$1.71n/a10
Dec ’25US$2.30
US$2.26
-1.6%
11.2%US$2.61US$1.80n/a10
Nov ’25US$2.00
US$2.44
+22.0%
12.1%US$2.90US$1.90n/a11
Oct ’25US$2.51
US$2.44
-2.6%
12.1%US$2.90US$1.90n/a11
Sep ’25n/a
US$2.36
0%
12.5%US$2.85US$1.86n/a12
Aug ’25n/a
US$2.17
0%
16.8%US$2.73US$1.66n/a12
Jul ’25n/a
US$2.10
0%
16.4%US$2.75US$1.67n/a12
Jun ’25US$1.92
US$2.10
+9.2%
16.4%US$2.75US$1.67n/a12
May ’25US$1.85
US$2.10
+13.3%
16.4%US$2.75US$1.67n/a12
Apr ’25n/a
US$2.10
0%
16.4%US$2.75US$1.67n/a12
Mar ’25n/a
US$2.10
0%
16.4%US$2.75US$1.67n/a12
Feb ’25US$2.05
US$2.48
+20.8%
15.6%US$3.30US$1.87n/a11
Jan ’25US$2.84
US$3.01
+6.1%
14.7%US$3.61US$2.41US$2.1012
Dec ’24n/a
US$2.95
0%
17.9%US$4.12US$2.32US$2.3012
Nov ’24n/a
US$2.95
0%
17.9%US$4.12US$2.32US$2.0012
Oct ’24US$2.83
US$3.02
+6.6%
17.1%US$4.18US$2.41US$2.5112
Sep ’24n/a
US$2.94
0%
18.6%US$4.17US$2.14n/a13
Aug ’24n/a
US$3.15
0%
17.9%US$4.30US$2.21n/a13
Jul ’24US$3.07
US$3.11
+1.1%
19.1%US$4.27US$2.20n/a12
Jun ’24US$3.35
US$3.11
-7.3%
19.1%US$4.27US$2.20US$1.9212
May ’24US$3.78
US$3.11
-17.7%
18.8%US$4.29US$2.20US$1.8512
Apr ’24n/a
US$3.00
0%
15.5%US$3.96US$2.20n/a12
Mar ’24US$2.92
US$3.01
+3.0%
12.9%US$3.61US$2.26n/a12
Feb ’24US$3.37
US$3.15
-6.5%
14.3%US$3.87US$2.29US$2.0511
Jan ’24n/a
US$2.92
0%
16.4%US$3.72US$2.20US$2.8411

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 13:58
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nanosonics Limited is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Josh KannourakisBarrenjoey Markets Pty Limited
John HesterBell Potter